Although ex vivo studies on the effect of NAC on alveolar macrophages from IPF patients showed downregulation of LPS-induced TNF-α production, a very recent study comparing NAC and placebo in IPF showed no impact on the rate of decline in pulmonary function tests or rate of death [103,104]. Here, TNF is linked to idiopathic pulmonary fibrosis.